ENCell Co., Ltd. (KOSDAQ:456070)
South Korea
· Delayed Price · Currency is KRW 15,920
+920 (6.13%)
Mar 10, 2026, 10:30 AM KST
ENCell Market Cap
ENCell has a market cap or net worth of 164.47 billion as of March 9, 2026. Its market cap has decreased by -12.31% in one year.
Market Cap
164.47B
Enterprise Value
147.43B
Revenue
5.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,920.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has increased from 160.82B to 164.47B, an increase of 2.27%. That is a compound annual growth rate of 1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 177.52B | -10.57% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 174.46B |
| Macrogen | 185.06B |
| Vaxcell-Bio Therapeutics | 195.83B |
| iNtRON Biotechnology | 197.72B |
| Genexine | 231.04B |
| EASY BIO,Inc. | 233.89B |
| HLB Therapeutics | 241.80B |
| CG Invites | 111.96B |